Industry: Medical Devices & Consumables
Published Date: 2024-08-11
Pages: 96 Pages
Report ld: 3277734
Request Sample
Customized Report
Fully Automatic Molecular Diagnostic System is an automated platform that integrates sample processing, nucleic acid extraction, amplification, detection and result analysis. It is mainly used to detect DNA, RNA or other molecular markers. The system can automatically complete the entire process from sample to result, reduce human intervention, reduce contamination risks, and improve the accuracy and efficiency of detection. The fully automatic molecular diagnostic system is widely used in clinical diagnosis, infectious disease detection, tumor marker detection, genetic research and other fields.
The global Fully Automatic Molecular Diagnostic System market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Fully Automatic Molecular Diagnostic System is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Fully Automatic Molecular Diagnostic System is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Fully Automatic Molecular Diagnostic System include Roche, Abbott Molecular, Hologic, QIAGEN, Cepheid, BD, bioMérieux, Thermo Fisher Scientific, Siemens Healthineers, Beckman Coulter, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Fully Automatic Molecular Diagnostic System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fully Automatic Molecular Diagnostic System.
The Fully Automatic Molecular Diagnostic System market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Fully Automatic Molecular Diagnostic System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Fully Automatic Molecular Diagnostic System manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Roche
Abbott Molecular
Hologic
QIAGEN
Cepheid
BD
bioMérieux
Thermo Fisher Scientific
Siemens Healthineers
Beckman Coulter
Promega
Fapon Biotech
Segment by Type
Real-Time PCR Systems
Multiplex PCR Systems
Others
Segment by Application
Clinical Diagnosis
Genetic Research
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Fully Automatic Molecular Diagnostic System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Fully Automatic Molecular Diagnostic System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Fully Automatic Molecular Diagnostic System Market Overview
1.1 Product Definition
1.2 Fully Automatic Molecular Diagnostic System by Type
1.2.1 Global Fully Automatic Molecular Diagnostic System Market Value Comparison by Type (2024-2030)
1.2.2 Real-Time PCR Systems
1.2.3 Multiplex PCR Systems
1.2.4 Others
1.3 Fully Automatic Molecular Diagnostic System by Application
1.3.1 Global Fully Automatic Molecular Diagnostic System Market Value by Application (2024-2030)
1.3.2 Clinical Diagnosis
1.3.3 Genetic Research
1.3.4 Others
1.4 Global Fully Automatic Molecular Diagnostic System Market Size Estimates and Forecasts
1.4.1 Global Fully Automatic Molecular Diagnostic System Revenue 2019-2030
1.4.2 Global Fully Automatic Molecular Diagnostic System Sales 2019-2030
1.4.3 Global Fully Automatic Molecular Diagnostic System Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Fully Automatic Molecular Diagnostic System Market Competition by Manufacturers
2.1 Global Fully Automatic Molecular Diagnostic System Sales Market Share by Manufacturers (2019-2024)
2.2 Global Fully Automatic Molecular Diagnostic System Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Fully Automatic Molecular Diagnostic System Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Fully Automatic Molecular Diagnostic System, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Fully Automatic Molecular Diagnostic System, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Fully Automatic Molecular Diagnostic System, Product Type & Application
2.7 Global Key Manufacturers of Fully Automatic Molecular Diagnostic System, Date of Enter into This Industry
2.8 Global Fully Automatic Molecular Diagnostic System Market Competitive Situation and Trends
2.8.1 Global Fully Automatic Molecular Diagnostic System Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Fully Automatic Molecular Diagnostic System Players Market Share by Revenue
2.8.3 Global Fully Automatic Molecular Diagnostic System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Fully Automatic Molecular Diagnostic System Market Scenario by Region
3.1 Global Fully Automatic Molecular Diagnostic System Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Fully Automatic Molecular Diagnostic System Sales by Region: 2019-2030
3.2.1 Global Fully Automatic Molecular Diagnostic System Sales by Region: 2019-2024
3.2.2 Global Fully Automatic Molecular Diagnostic System Sales by Region: 2025-2030
3.3 Global Fully Automatic Molecular Diagnostic System Revenue by Region: 2019-2030
3.3.1 Global Fully Automatic Molecular Diagnostic System Revenue by Region: 2019-2024
3.3.2 Global Fully Automatic Molecular Diagnostic System Revenue by Region: 2025-2030
3.4 North America Fully Automatic Molecular Diagnostic System Market Facts & Figures by Country
3.4.1 North America Fully Automatic Molecular Diagnostic System Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Fully Automatic Molecular Diagnostic System Sales by Country (2019-2030)
3.4.3 North America Fully Automatic Molecular Diagnostic System Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Fully Automatic Molecular Diagnostic System Market Facts & Figures by Country
3.5.1 Europe Fully Automatic Molecular Diagnostic System Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Fully Automatic Molecular Diagnostic System Sales by Country (2019-2030)
3.5.3 Europe Fully Automatic Molecular Diagnostic System Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Fully Automatic Molecular Diagnostic System Market Facts & Figures by Region
3.6.1 Asia Pacific Fully Automatic Molecular Diagnostic System Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Fully Automatic Molecular Diagnostic System Sales by Region (2019-2030)
3.6.3 Asia Pacific Fully Automatic Molecular Diagnostic System Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Fully Automatic Molecular Diagnostic System Market Facts & Figures by Country
3.7.1 Latin America Fully Automatic Molecular Diagnostic System Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Fully Automatic Molecular Diagnostic System Sales by Country (2019-2030)
3.7.3 Latin America Fully Automatic Molecular Diagnostic System Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Fully Automatic Molecular Diagnostic System Market Facts & Figures by Country
3.8.1 Middle East and Africa Fully Automatic Molecular Diagnostic System Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Fully Automatic Molecular Diagnostic System Sales by Country (2019-2030)
3.8.3 Middle East and Africa Fully Automatic Molecular Diagnostic System Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Fully Automatic Molecular Diagnostic System Sales by Type (2019-2030)
4.1.1 Global Fully Automatic Molecular Diagnostic System Sales by Type (2019-2024)
4.1.2 Global Fully Automatic Molecular Diagnostic System Sales by Type (2025-2030)
4.1.3 Global Fully Automatic Molecular Diagnostic System Sales Market Share by Type (2019-2030)
4.2 Global Fully Automatic Molecular Diagnostic System Revenue by Type (2019-2030)
4.2.1 Global Fully Automatic Molecular Diagnostic System Revenue by Type (2019-2024)
4.2.2 Global Fully Automatic Molecular Diagnostic System Revenue by Type (2025-2030)
4.2.3 Global Fully Automatic Molecular Diagnostic System Revenue Market Share by Type (2019-2030)
4.3 Global Fully Automatic Molecular Diagnostic System Price by Type (2019-2030)
5 Segment by Application
5.1 Global Fully Automatic Molecular Diagnostic System Sales by Application (2019-2030)
5.1.1 Global Fully Automatic Molecular Diagnostic System Sales by Application (2019-2024)
5.1.2 Global Fully Automatic Molecular Diagnostic System Sales by Application (2025-2030)
5.1.3 Global Fully Automatic Molecular Diagnostic System Sales Market Share by Application (2019-2030)
5.2 Global Fully Automatic Molecular Diagnostic System Revenue by Application (2019-2030)
5.2.1 Global Fully Automatic Molecular Diagnostic System Revenue by Application (2019-2024)
5.2.2 Global Fully Automatic Molecular Diagnostic System Revenue by Application (2025-2030)
5.2.3 Global Fully Automatic Molecular Diagnostic System Revenue Market Share by Application (2019-2030)
5.3 Global Fully Automatic Molecular Diagnostic System Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Company Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Fully Automatic Molecular Diagnostic System Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Roche Fully Automatic Molecular Diagnostic System Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Abbott Molecular
6.2.1 Abbott Molecular Company Information
6.2.2 Abbott Molecular Description and Business Overview
6.2.3 Abbott Molecular Fully Automatic Molecular Diagnostic System Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Abbott Molecular Fully Automatic Molecular Diagnostic System Product Portfolio
6.2.5 Abbott Molecular Recent Developments/Updates
6.3 Hologic
6.3.1 Hologic Company Information
6.3.2 Hologic Description and Business Overview
6.3.3 Hologic Fully Automatic Molecular Diagnostic System Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Hologic Fully Automatic Molecular Diagnostic System Product Portfolio
6.3.5 Hologic Recent Developments/Updates
6.4 QIAGEN
6.4.1 QIAGEN Company Information
6.4.2 QIAGEN Description and Business Overview
6.4.3 QIAGEN Fully Automatic Molecular Diagnostic System Sales, Revenue and Gross Margin (2019-2024)
6.4.4 QIAGEN Fully Automatic Molecular Diagnostic System Product Portfolio
6.4.5 QIAGEN Recent Developments/Updates
6.5 Cepheid
6.5.1 Cepheid Company Information
6.5.2 Cepheid Description and Business Overview
6.5.3 Cepheid Fully Automatic Molecular Diagnostic System Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Cepheid Fully Automatic Molecular Diagnostic System Product Portfolio
6.5.5 Cepheid Recent Developments/Updates
6.6 BD
6.6.1 BD Company Information
6.6.2 BD Description and Business Overview
6.6.3 BD Fully Automatic Molecular Diagnostic System Sales, Revenue and Gross Margin (2019-2024)
6.6.4 BD Fully Automatic Molecular Diagnostic System Product Portfolio
6.6.5 BD Recent Developments/Updates
6.7 bioMérieux
6.7.1 bioMérieux Company Information
6.7.2 bioMérieux Description and Business Overview
6.7.3 bioMérieux Fully Automatic Molecular Diagnostic System Sales, Revenue and Gross Margin (2019-2024)
6.7.4 bioMérieux Fully Automatic Molecular Diagnostic System Product Portfolio
6.7.5 bioMérieux Recent Developments/Updates
6.8 Thermo Fisher Scientific
6.8.1 Thermo Fisher Scientific Company Information
6.8.2 Thermo Fisher Scientific Description and Business Overview
6.8.3 Thermo Fisher Scientific Fully Automatic Molecular Diagnostic System Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Thermo Fisher Scientific Fully Automatic Molecular Diagnostic System Product Portfolio
6.8.5 Thermo Fisher Scientific Recent Developments/Updates
6.9 Siemens Healthineers
6.9.1 Siemens Healthineers Company Information
6.9.2 Siemens Healthineers Description and Business Overview
6.9.3 Siemens Healthineers Fully Automatic Molecular Diagnostic System Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Siemens Healthineers Fully Automatic Molecular Diagnostic System Product Portfolio
6.9.5 Siemens Healthineers Recent Developments/Updates
6.10 Beckman Coulter
6.10.1 Beckman Coulter Company Information
6.10.2 Beckman Coulter Description and Business Overview
6.10.3 Beckman Coulter Fully Automatic Molecular Diagnostic System Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Beckman Coulter Fully Automatic Molecular Diagnostic System Product Portfolio
6.10.5 Beckman Coulter Recent Developments/Updates
6.11 Promega
6.11.1 Promega Company Information
6.11.2 Promega Description and Business Overview
6.11.3 Promega Fully Automatic Molecular Diagnostic System Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Promega Fully Automatic Molecular Diagnostic System Product Portfolio
6.11.5 Promega Recent Developments/Updates
6.12 Fapon Biotech
6.12.1 Fapon Biotech Company Information
6.12.2 Fapon Biotech Description and Business Overview
6.12.3 Fapon Biotech Fully Automatic Molecular Diagnostic System Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Fapon Biotech Fully Automatic Molecular Diagnostic System Product Portfolio
6.12.5 Fapon Biotech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Fully Automatic Molecular Diagnostic System Industry Chain Analysis
7.2 Fully Automatic Molecular Diagnostic System Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Fully Automatic Molecular Diagnostic System Production Mode & Process
7.4 Fully Automatic Molecular Diagnostic System Sales and Marketing
7.4.1 Fully Automatic Molecular Diagnostic System Sales Channels
7.4.2 Fully Automatic Molecular Diagnostic System Distributors
7.5 Fully Automatic Molecular Diagnostic System Customers
8 Fully Automatic Molecular Diagnostic System Market Dynamics
8.1 Fully Automatic Molecular Diagnostic System Industry Trends
8.2 Fully Automatic Molecular Diagnostic System Market Drivers
8.3 Fully Automatic Molecular Diagnostic System Market Challenges
8.4 Fully Automatic Molecular Diagnostic System Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Fully Automatic Molecular Diagnostic System market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-26
Pages: 166
USD 4900.00
(Single User License)
The global Fully Automatic Molecular Diagnostic System market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 96
USD 4250.00
(Single User License)
The global Fully Automatic Molecular Diagnostic System market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-09
Pages: 123
USD 2900.00
(Single User License)
The global market for Fully Automatic Molecular Diagnostic System was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-09
Pages: 117
USD 3950.00
(Single User License)
The global Fully Automatic Molecular Diagnostic System market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 170
USD 4900.00
(Single User License)
The global Fully Automatic Molecular Diagnostic System market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 98
USD 4250.00
(Single User License)
The global market for Fully Automatic Molecular Diagnostic System was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 117
USD 3950.00
(Single User License)
The global market for Fully Automatic Molecular Diagnostic System was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-10
Pages: 96
USD 2900.00
(Single User License)
Fully Automatic Molecular Diagnostic System is an automated platform that integrates sample processing, nucleic acid extraction, amplification, detection and result analysis. It is mainly used to detect DNA, RNA or other molecular markers. The system can automatically complete the entire process from sample to result, reduce human intervention, reduce contamination risks, and improve the accuracy and efficiency of detection. The fully automatic molecular diagnostic system is widely used in clinical diagnosis, infectious disease detection, tumor marker detection, genetic research and other fields.
Published Date: 2024-08-11
Pages: 165
USD 4900.00
(Single User License)
Fully Automatic Molecular Diagnostic System is an automated platform that integrates sample processing, nucleic acid extraction, amplification, detection and result analysis. It is mainly used to detect DNA, RNA or other molecular markers. The system can automatically complete the entire process from sample to result, reduce human intervention, reduce contamination risks, and improve the accuracy and efficiency of detection. The fully automatic molecular diagnostic system is widely used in clinical diagnosis, infectious disease detection, tumor marker detection, genetic research and other fields.
Published Date: 2024-08-11
Pages: 132
USD 4350.00
(Single User License)
The global Fully Automatic Molecular Diagnostic System market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 166
The global Fully Automatic Molecular Diagnostic System market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 96
The global Fully Automatic Molecular Diagnostic System market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-09
Pages: 123
The global market for Fully Automatic Molecular Diagnostic System was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-09
Pages: 117
The global Fully Automatic Molecular Diagnostic System market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 170
The global Fully Automatic Molecular Diagnostic System market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 98
The global market for Fully Automatic Molecular Diagnostic System was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 117
The global market for Fully Automatic Molecular Diagnostic System was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-10
Pages: 96
Fully Automatic Molecular Diagnostic System is an automated platform that integrates sample processing, nucleic acid extraction, amplification, detection and result analysis. It is mainly used to detect DNA, RNA or other molecular markers. The system can automatically complete the entire process from sample to result, reduce human intervention, reduce contamination risks, and improve the accuracy and efficiency of detection. The fully automatic molecular diagnostic system is widely used in clinical diagnosis, infectious disease detection, tumor marker detection, genetic research and other fields.
Published: 2024-08-11
Pages: 165
Fully Automatic Molecular Diagnostic System is an automated platform that integrates sample processing, nucleic acid extraction, amplification, detection and result analysis. It is mainly used to detect DNA, RNA or other molecular markers. The system can automatically complete the entire process from sample to result, reduce human intervention, reduce contamination risks, and improve the accuracy and efficiency of detection. The fully automatic molecular diagnostic system is widely used in clinical diagnosis, infectious disease detection, tumor marker detection, genetic research and other fields.
Published: 2024-08-11
Pages: 132
REPORT COVERAGE
DESCRIPTION
OVERVIEW
REPORT SCOPE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now